SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 642.25-1.5%Nov 3 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
CuttingEdge Bio
To: Miljenko Zuanic who wrote (3432)2/4/2022 6:58:35 PM
From: BioBait1 Recommendation   of 3557
 
Regn-COV2 reported 7.5b in revenue. Even if there’s no gen2 it’s a big win. Moving quickly, allowed regn to capture opportunity. Compared to vir. Quicker manufacturing and fda approval would have been nice.
Sadly, I don’t believe fda will move quickly on gen2.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News